Phreesia (NYSE:PHR – Free Report) had its price target reduced by Needham & Company LLC from $35.00 to $14.00 in a research report report published on Tuesday, Marketbeat reports. They currently have a buy rating on the stock.
PHR has been the topic of a number of other research reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Phreesia in a research note on Wednesday, January 28th. Wall Street Zen downgraded Phreesia from a “strong-buy” rating to a “buy” rating in a research report on Sunday, February 8th. Zacks Research lowered shares of Phreesia from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 6th. Mizuho decreased their price target on Phreesia from $22.00 to $19.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 24th. Finally, DA Davidson lowered their price objective on shares of Phreesia from $35.00 to $30.00 and set a “buy” rating for the company in a research report on Friday, January 23rd. Twelve research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $22.00.
Get Our Latest Analysis on PHR
Phreesia Stock Down 0.6%
Phreesia (NYSE:PHR – Get Free Report) last announced its quarterly earnings results on Monday, March 30th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.05). The company had revenue of $127.07 million during the quarter, compared to the consensus estimate of $126.75 million. Phreesia had a net margin of 0.48% and a return on equity of 3.33%. The business’s revenue was up 15.9% compared to the same quarter last year. During the same period last year, the company earned ($0.11) earnings per share. On average, analysts predict that Phreesia will post -1.1 earnings per share for the current year.
Insiders Place Their Bets
In other Phreesia news, insider Evan Roberts sold 6,317 shares of the firm’s stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total value of $107,452.17. Following the completion of the transaction, the insider directly owned 834,632 shares of the company’s stock, valued at $14,197,090.32. This trade represents a 0.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider David Linetsky sold 6,106 shares of the company’s stock in a transaction dated Thursday, January 8th. The stock was sold at an average price of $17.01, for a total value of $103,863.06. Following the completion of the transaction, the insider owned 231,723 shares in the company, valued at $3,941,608.23. This represents a 2.57% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 70,358 shares of company stock worth $1,123,569 in the last ninety days. Company insiders own 5.50% of the company’s stock.
Institutional Trading of Phreesia
Several hedge funds and other institutional investors have recently bought and sold shares of PHR. Vanguard Group Inc. lifted its holdings in Phreesia by 8.3% in the 3rd quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company’s stock worth $134,177,000 after buying an additional 437,462 shares during the period. New York State Common Retirement Fund lifted its position in Phreesia by 727.1% during the 3rd quarter. New York State Common Retirement Fund now owns 136,856 shares of the company’s stock valued at $3,219,000 after acquiring an additional 120,309 shares during the period. Squarepoint Ops LLC boosted its position in shares of Phreesia by 243.6% in the 2nd quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock worth $2,872,000 after purchasing an additional 71,553 shares in the last quarter. Greenhouse Funds LLLP increased its holdings in shares of Phreesia by 16.8% during the third quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock valued at $91,317,000 after acquiring an additional 557,265 shares in the last quarter. Finally, Bessemer Group Inc. increased its stake in Phreesia by 1,065.9% during the 3rd quarter. Bessemer Group Inc. now owns 554,513 shares of the company’s stock valued at $13,043,000 after purchasing an additional 506,954 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.
Phreesia News Roundup
Here are the key news stories impacting Phreesia this week:
- Positive Sentiment: Analyst take: a MarketBeat piece argues Phreesia may have hit a trough and is well?positioned to regain growth and market share over time, suggesting upside if execution and demand stabilize. Phreesia Hits Bottom in Q1: Rebound Ahead, Timing Uncertain
- Neutral Sentiment: Several large firms have issued neutral/market?perform ratings (Robert W. Baird, JPMorgan, Citigroup), signaling limited near?term conviction rather than outright sell ratings. Phreesia (NYSE:PHR) Earns “Neutral” Rating from Robert W. Baird
- Neutral Sentiment: Citizens JMP reaffirmed a market?perform view, reflecting tepid near?term expectations from another sell?side firm. Citizens JMP Market Perform Reaffirmed
- Neutral Sentiment: Investor comparison coverage contrasts Phreesia with peers (MSP Recovery), providing context but not a clear directional trigger. Phreesia and MSP Recovery Critical Contrast
- Negative Sentiment: Primary catalyst: Phreesia reported its first full?year profit but issued lower FY2027 revenue guidance, prompting a sharp selloff as investors focused on the reduced top?line outlook. Phreesia (PHR) Is Down 25.5% After First Full-Year Profit But Lower 2027 Revenue Guidance
- Negative Sentiment: Multiple analysts cut expectations and targets (Canaccord cut its price target to $22; Needham, Stephens and BMO issued more pessimistic views), increasing selling pressure and lowering implied valuation. Needham Lowers Expectations for Phreesia BMO Capital Markets Issues Pessimistic Forecast for Phreesia Needham & Company LLC Has Lowered Expectations for Phreesia
- Negative Sentiment: The stock hit a new one?year low after the earnings/guide miss, a technical signal that can accelerate outflows from momentum and quant funds. Phreesia Reaches New 1-Year Low After Earnings Miss
- Negative Sentiment: Legal risk: a law firm announced an investigation into potential securities?law violations tied to prior guidance comments, adding uncertainty and potential headline risk. Investors in Phreesia Warned of Potential Securities Fraud
- Negative Sentiment: Some outlets and analysts pulled recommendations or expressed disappointment in growth guidance, reinforcing negative sentiment. Phreesia’s growth guidance disappointed. We’re pulling our recommendation.
About Phreesia
Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.
Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.
See Also
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.
